Serum 款-glutamyltransferase level and metabolic syndrome in children and adolescents: Korean National Health and Nutrition Examination Survey by 諛뺤옱誘� et al.
Serum c-glutamyltransferase level and
metabolic syndrome in children and
adolescents: Korean National Health and
Nutrition Examination Survey
Jae-Min Park1, Jee-Yon Lee2 , Duk-Chul Lee3, Yong-Jae Lee3*
1Department of Family Medicine, Konkuk University Medical Center, 2Department of Family Medicine, CHA University College of Medicine, Chaum Life Center, CHA Bundang
Medical Center, and 3Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea
Keywords
c-Glutamyltransferase, Childhood
obesity, Metabolic syndrome
*Correspondence
Yong-Jae Lee
Tel.: +82-2-2019-2630
Fax: +82-3462-8209
E-mail address:
ukyjhome@yuhs.ac
J Diabetes Investig 2018; 9: 522–528
doi: 10.1111/jdi.12716
ABSTRACT
Aims/Introduction: Serum c-glutamyltransferase (GGT) is positively related to car-
diometabolic diseases, such as type 2 diabetes mellitus, hypertension and metabolic syn-
drome (MetS), in adult populations. Our aim was to investigate whether serum GGT is
independently associated with MetS and its components in a nationally representative
sample of Korean children and adolescents.
Materials and Methods: The study included data from 1,618 participants (867 boys,
751 girls) aged 10–18 years from the 2010–2011 Korean National Health and Nutrition
Examination Survey. MetS was diagnosed by the 2007 International Diabetes Federation
criteria for children and adolescents. Participants were stratified using a cut-off value of
the 75th percentile of serum GGT levels (19 IU/L for boys, 15 IU/L for girls). The odds
ratios and 95% confidence intervals for MetS and its components were determined with
multiple logistic regression analyses.
Results: The mean values of most cardiometabolic variables were significantly higher in
the upper stratum. Except for low high-density lipoprotein cholesterol in boys and ele-
vated blood pressure in girls, participants in the upper GGT stratum had significantly
higher odds of MetS and its components than those in the lower stratum. The multivari-
ate-adjusted odds ratios for MetS for the upper stratum were 5.79 (95% confidence inter-
val 1.21–27.02) in boys and 6.20 (95% confidence interval 1.71–22.47) in girls, after
adjusting for age, household income and residential area.
Conclusions: Serum GGT was positively associated with MetS and its components in
Korean children and adolescents. Serum GGT could be a useful measure for identifying
children and adolescents with MetS.
INTRODUCTION
Metabolic syndrome (MetS), which is a cluster of metabolic
abnormalities that include abdominal obesity, high blood pres-
sure, glucose intolerance and dyslipidemia, is a risk factor for
type 2 diabetes mellitus, cardiovascular disease and certain can-
cers1,2. All these diseases are leading causes of mortality in
adults; however, abnormalities of components of MetS are
observed during childhood and can persist into adulthood3,4.
With the ongoing obesity epidemic among children and
adolescents, MetS is important in public health perspectives in
this population5,6. Thus, biomarkers for the identiﬁcation of
individuals with MetS or at risk for MetS development among
the pediatric population are crucial for better management of
this syndrome.
The membrane-bound glycoprotein, c-glutamyltransferase
(GGT), is a microsomal enzyme that carries out a key function
in extracellular catabolism of glutathione (c-L-glutamyl-L-cystei-
nyl-glycine), which is a signiﬁcant anti-oxidant against oxidative
stress and free radicals, and is responsible for maintaining glu-
tathione homeostasis7. GGT is present in serum and on the
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outer surface of most human cells, especially in tissues that
carry out transport functions, such as the bile duct and
kidneys8.
Although an increase in the GGT level has traditionally been
recognized as a marker of hepatobiliary disease or inordinate
alcohol consumption8,9, recent epidemiological research has
shown that the serum GGT level can be used to predict the
development of cardiometabolic diseases, such as hypertension10,
insulin resistance11, type 2 diabetes mellitus12 and MetS13, in
adults. However, few studies have examined the relationship
between the serum GGT level and MetS in the general pediatric
population. Although a previous study examined the association
between the serum GGT level and insulin resistance in obese
children, the study focused on only overweight/obese children
and did not include a non-obese pediatric population14. There-
fore, the present study aimed to investigate the association
between the serum GGT level and MetS in a nationally repre-
sentative sample of Korean children and adolescents.
METHODS
Survey overview and study population
The present cross-sectional study utilized data collected from
the 2010–2011 Korean National Health and Nutrition Exami-
nation Survey (KNHANES), which was carried out by the
Korea Centers for Disease Control and Prevention15. The
KNHANES is a nationwide, representative, population-based
survey carried out to evaluate the health and nutrition status of
Koreans. The target population of the KNHANES was the civil-
ian non-institutionalized people of Korea. The sampling units
were composed of families that were selected through a strati-
ﬁed, multistage probability sampling design based on sex distri-
bution, geographic area and age. Sampling weights that were
representative of the probability of being sampled were allo-
cated to each participant to ensure that the results represented
the overall Korean population.
Of the 2,018 children and adolescents aged 10–18 years who
participated in the 2010–2011 KNHANES, we excluded those
who had not fasted for 12 h before blood sampling (n = 191),
those with missing data (n = 181) and those who had a serum
GGT level higher than the upper limit of the normal range
(n = 26). We also excluded individuals with positive serological
ﬁndings for hepatitis B (n = 2). Finally, 1,618 participants (867
boys and 751 girls) were included in the ﬁnal analysis. Written
informed consent was acquired from all citizens who agreed to
participate. The KNHANES was approved by the Korea Cen-
ters for Disease Control and Prevention Institutional Review
Board (approval numbers: 2010-02CON-21-C and 2011-
02CON-06-C). Additionally, this study complied with the ethi-
cal principles of the Declaration of Helsinki.
Measurement of anthropometric and laboratory data
Educated medical staff carried out the anthropometric measure-
ments following a standardized procedure. Height and body-
weight were obtained to the nearest 0.1 cm and 0.1 kg,
respectively, while participants wore light clothing without
shoes. The body mass index (BMI) was computed as weight
(kg) divided by the square of height (m2). BMI z-scores were
determined with the modiﬁed lambda, mu, sigma statistical
method applied in the growth charts issued by the Korean
Pediatric Society in 200716. Waist circumference (WC) was
obtained to the nearest 0.1 cm at the midpoint between the
iliac crest and the lower border of the rib cage at the end stage
of natural expiration. Blood pressure (BP) was obtained on the
right arm three separate times at 5-min intervals with a typical
mercury sphygmomanometer (Baumanometer; W.A. Baum
Co., Inc., Copiague, NY, USA), and the mean of the second
and third assessments was used in the analysis.
Venous blood was drawn from the antecubital vein in each
participant after a minimum 12-h fast. Fasting plasma glucose,
total cholesterol, triglycerides (TG), high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol, aspar-
tate aminotransferase, alanine aminotransferase and GGT levels
were determined with an automatic analyzer (Hitachi 7600;
Hitachi Co., Tokyo, Japan). White blood cell (WBC) count was
analyzed using an automated blood cell counter (XE-2100D;
Sysmex, Kobe, Japan).
Deﬁnition of clinical variables
MetS was diagnosed by the 2007 International Diabetes Federa-
tion consensus deﬁnition of MetS in children and adolescents17.
According to the International Diabetes Federation deﬁnition,
MetS, as an entity, is not diagnosed in children below the age
of 10 years, and an individual aged ≥10 years can be diagnosed
with MetS when abdominal obesity is noted along with at least
two of the following four factors: (i) TG ≥150 mg/dL; (ii)
HDL-C <40 mg/dL for girls aged <16 years and boys of all
ages, and HDL-C <50 mg/dL for girls aged ≥16 years; (iii) sys-
tolic BP ≥130 mmHg or diastolic BP ≥85 mmHg; and (iv) fast-
ing plasma glucose ≥100 mg/dL. Abdominal obesity was
deﬁned as a WC ≥90th percentile for age and sex for individu-
als aged <16 years, and a WC ≥90 cm and ≥80 cm for boys
and girls, respectively, aged ≥16 years. The cut-off value for
WC in individuals <16 years was based on the 2007 Korean
Children and Adolescents Growth Standard16. Overweight was
deﬁned as BMI in the 85–95th percentile for age and sex, and
obesity was deﬁned as a BMI ≥95th percentile for age and sex
according to the 2007 Korean Children and Adolescents
Growth Standard16. Participants were divided into an upper
and a lower stratum according to a cut-off value of the 75th
percentile of serum GGT, which in the present study was
19 IU/L for boys and 15 IU/L for girls, respectively.
Statistical analysis
Sampling units were obtained from a stratiﬁed, multistage,
probability sampling design that was based on the sex, age and
geographical area of participants, using household registries.
The characteristics of the study participants were assessed using
a weighted t-test for continuous variables, and a weighted
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v2-test for categorical variables. Age-adjusted mean serum GGT
values were obtained by carrying out analysis of covariance
(ANCOVA) according to the number of MetS components. To
determine the clinical application of serum GGT in predicting
MetS, the receiver operating characteristic (ROC) curves of
serum GGT for MetS diagnosis were derived, and the area
under the ROC curve was calculated for boys and girls. The
odds ratios and 95% conﬁdence intervals (95% CI) for abdomi-
nal obesity, elevated BP, high fasting plasma glucose, high TG,
low HDL-C and MetS were determined with multiple logistic
regression analysis after adjusting for potential confounding fac-
tors. All statistical analyses were carried out with SPSS version
24 (IBM Corporation, Chicago, IL, USA). A P-value <0.05 was
considered signiﬁcant.
RESULTS
Table 1 shows the characteristics of study participants. The
mean values of most cardiometabolic variables, such as BMI,
BMI z-score, WC, waist-to-height ratio, total cholesterol, TG,
low-density lipoprotein cholesterol levels and WBC count, were
signiﬁcantly higher in the upper stratum of GGT than in the
lower stratum.
Table 2 presents the prevalence of MetS and each of its com-
ponents. The overall prevalence rate of MetS according to the
International Diabetes Federation deﬁnition was 1.7% among
boys and 2.7% among girls. The prevalence of abdominal obe-
sity and low HDL-C was higher in girls than in boys, whereas
elevated BP was more prevalent in boys than in girls. The
prevalence of MetS and most of its components was signiﬁ-
cantly higher in the upper stratum of GGT than in the lower
stratum in both boys and girls.
The age-adjusted mean GGT levels according to the number
of MetS components are presented in Figure 1. The age-
adjusted mean GGT level increased progressively with the pres-
ence of each additional MetS component in both boys and girls
(P for trend <0.001). The mean GGT levels were 15.9, 18.7,
26.4 and 31.1 IU/L in boys, and 12.4, 12.8, 15.5 and 19.1 IU/L
in girls, with 0, 1, 2 and ≥3 MetS components, respectively.
Figure 2 illustrates the ROC curves of serum GGT for
MetS. The area under the ROC curve was 0.823 (95% CI
0.701–0.946) in boys and 0.752 (95% CI 0.605–0.898) in girls,
respectively.
Table 3 presents the prevalence risk of MetS and its compo-
nents according to GGT level. In comparison with participants
in the lower stratum of GGT, those in the upper stratum of
GGT had signiﬁcantly higher odds of MetS and its components
except for low HDL-C in boys and elevated BP in girls. The
multivariate-adjusted odds ratios for MetS in the upper stratum
Table 1 | Characteristics of study participants
Boys Girls P-value Boys Girls
GGT ≤18 IU/L GGT ≥19 IU/L P-value GGT ≤14 IU/L GGT ≥15 IU/L P-value
Unweighted (n) 867 751 641 226 569 182
Age (years) 14.3 (0.1) 14.2 (0.1) 0.569 13.9 (0.1) 15.1 (0.2) <0.001 14.0 (0.1) 14.6 (0.3) 0.051
BMI (kg/m²) 20.9 (0.2) 20.4 (0.2) 0.048 19.9 (0.1) 23.5 (0.3) <0.001 19.8 (0.1) 22.2 (0.5) <0.001
BMI z-score –0.04 (0.05) 0.04 (0.05) 0.263 -0.27 (0.05) 0.54 (0.10) <0.001 –0.13 (0.05) 0.50 (0.15) <0.001
Overweight (%) 11.1 (1.2) 11.0 (1.4) 0.980 7.2 (1.1) 21.1 (3.1) <0.001 10.5 (1.6) 12.6 (2.7) 0.468
Obesity (%) 7.0 (1.1) 8.3 (1.3) 0.477 1.9 (0.6) 20.3 (3.4) <0.001 3.6 (0.9) 21.8 (4.2) <0.001
WC (cm) 71.5 (0.4) 67.6 (0.4) <0.001 68.8 (0.4) 78.5 (0.9) <0.001 66.0 (0.4) 71.9 (1.1) <0.001
Waist-to-height ratio 0.43 (0.00) 0.43 (0.00) 0.267 0.42 (0.00) 0.47 (0.01) <0.001 0.42 (0.00) 0.46 (0.01) <0.001
SBP (mmHg) 109.4 (0.5) 103.8 (0.5) <0.001 107.9 (0.5) 113.2 (0.9) <0.001 103.6 (0.5) 104.4 (0.8) 0.384
DBP (mmHg) 67.5 (0.4) 65.5 (0.4) <0.001 66.7 (0.5) 69.5 (0.8) 0.003 65.1 (0.4) 66.5 (0.7) 0.068
FPG (mg/dL) 89.2 (0.3) 88.3 (0.30) 0.028 89.0 (0.3) 89.6 (0.6) 0.407 88.1 (0.3) 89.2 (0.7) 0.159
Total cholesterol (mg/dL) 153.1 (1.3) 162.7 (1.2) <0.001 150.7 (1.3) 159.6 (3.0) 0.005 159.5 (1.3) 171.9 (2.7) <0.001
TG (mg/dL) 80.6 (2.2) 85.5 (2.4) 0.117 73.6 (2.2) 98.8 (4.8) <0.001 80.7 (2.6) 99.4 (5.2) 0.001
HDL-C (mg/dL) 48.3 (0.4) 50.5 (0.4) <0.001 48.9 (0.4) 47.0 (0.7) 0.019 51.1 (0.5) 48.8 (0.8) 0.010
LDL-C (mg/dL) 91.4 (1.8) 97.5 (1.5) 0.010 87.8 (1.7) 99.3 (3.4) 0.017 93.2 (1.4) 108.0 (3.4) <0.001
AST (IU/L) 20.7 (0.4) 17.1 (0.2) <0.001 18.9 (0.2) 25.4 (1.1) <0.001 16.7 (0.2) 18.2 (0.4) 0.001
ALT (IU/L) 18.6 (0.8) 11.5 (0.3) <0.001 12.9 (0.3) 33.3 (2.6) <0.001 10.4 (0.2) 14.6 (0.8) <0.001
WBC count (cells/lL) 6,130 (71) 6,150 (71) 0.898 5,930 (74) 6,650 (146) 0.001 6,050 (82) 6,420 (116) 0.007
Household income
(US$/month)
4,602 (300) 4,384 (315) 0.565 4,431 (323) 5,048 (665) 0.400 4,299 (379) 4,633 (454) 0.557
Residence in rural area (%) 17.2 (2.9) 18.2 (3.3) 0.651 18.9 (3.3) 12.6 (3.1) 0.055 19.6 (3.4) 14.3 (4.8) 0.245
Data are presented as mean (standard error) or percentage (standard error). P-values were obtained by using weighted one-way ANOVA for continu-
ous variables or weighted v2-test for categorical variables. US$1 = 1,000 Korean won. ALT, alanine aminotransferase; AST, aspartate aminotransferase;
BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; GGT, c-glutamyltrans-
ferase; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TG, triglycerides; WBC, white blood cell; WC, waist circumference.
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of GGT were 5.79 (95% CI 1.21–27.02) in boys and 6.20 (95%
CI 1.71–22.47) in girls after adjusting for age, household
income and residential area.
DISCUSSION
In the present representative sample of Korean children and
adolescents, the serum GGT level was positively associated with
MetS after adjusting for potential confounding factors. These
ﬁndings are consistent with the results of previous studies show-
ing that GGT is a predictor of MetS in adults13, and show that
this association also exists in the pediatric population. Recently,
serum GGT level has been reported to be associated with MetS
in children and adolescents. Kong et al.18 reported that serum
GGT elevation was associated with MetS and its components in
Chinese children and adolescents. However, in that study, sex-
related differences were not fully considered, and separate analy-
ses for both sexes were not carried out. As serum GGT levels
differed signiﬁcantly by sex in the present study, sex-speciﬁc
analyses models would be more appropriate. In this regard, the
present study conﬁrmed that the associations between serum
GGT levels and MetS can be applied to both boys and girls,
through sex-speciﬁc multiple logistic regression analyses.
There were sex-related differences in the prevalence of some
components of MetS. Although the mechanism underlying
these differences is unclear, hormonal differences (such as sex
hormones) between boys and girls might explain this phe-
nomenon. Previous studies have shown that sex hormones and
sex hormone-binding globulin levels differ between boys and
Table 2 | Prevalence of metabolic syndrome and its components
Boys Girls P-value Boys Girls
GGT ≤18 IU/L GGT ≥19 IU/L P-value GGT ≤14 IU/L GGT ≥15 IU/L P-value
MetS (%) 1.7 (0.6) 2.7 (0.8) 0.273 0.6 (0.4) 4.5 (1.7) 0.001 1.2 (0.6) 6.8 (2.6) 0.003
Abdominal obesity (%) 7.9 (1.1) 12.0 (1.5) 0.026 2.3 (0.6) 22.6 (3.4) <0.001 7.2 (1.4) 25.8 (4.1) <0.001
Elevated BP (%) 5.6 (1.1) 0.5 (0.3) <0.001 3.2 (0.9) 11.9 (3.1) <0.001 0.6 (0.4) 1.0 (0.8) 0.636
High FPG (%) 6.1 (1.0) 5.7 (1.0) 0.769 4.9 (1.0) 9.1 (2.9) 0.043 4.4 (0.9) 9.6 (3.0) 0.041
High TG (%) 8.7 (1.4) 8.5 (1.3) 0.920 5.2 (1.2) 17.7 (3.5) <0.001 6.6 (1.3) 13.9 (3.1) 0.010
Low HDL-C (%) 18.1 (1.7) 25.0 (2.3) 0.010 16.8 (1.8) 21.5 (3.1) 0.141 20.1 (2.4) 38.9 (4.7) <0.001
Data are presented as percentage (standard error). P-values were obtained by using weighted v2-test. BP, blood pressure; FPG, fasting plasma
glucose; HDL-C, high-density lipoprotein cholesterol; GGT, c-glutamyltransferase; MetS, metabolic syndrome; TG, triglycerides.
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girls in the pubertal stage19, and are differentially associated
with lipid proﬁle in boys and girls20–22.
There are several possible mechanisms for the signiﬁcant
association between the serum GGT level and MetS in children
and adolescents. An increase in the GGT level could indicate
an increase in fat inﬁltration in the liver, and a higher GGT
level has been frequently observed in non-alcoholic fatty liver
disease23. Non-alcoholic fatty liver disease is increasingly being
regarded as a manifestation of MetS and insulin resistance24,25.
Fat inﬁltration in the liver has been shown to bring about insu-
lin resistance, and result in the overproduction of both glucose
and very low-density lipoprotein cholesterol, which can cause
hyperglycemia, hypertriglyceridemia, low HDL-C levels and
hypertension26–29.
Another possible factor to be considered is chronic low-grade
inﬂammation. Insulin resistance and the related MetS are
increasingly being recognized as subclinical inﬂammatory
states30,31. Inﬂammatory markers, such as the WBC count,
interleukin-6 and C-reactive protein, are believed to be inde-
pendent predictors of type 2 diabetes mellitus and cardiovascu-
lar disease32,33. Furthermore, growing evidence suggests that
GGT might be an inﬂammatory marker34. Indeed, in the cur-
rent study, the WBC count was considerably higher in partici-
pants in the upper GGT stratum than in those in the lower
GGT stratum. Furthermore, oxidative stress has been suggested
as a possible mechanism linking a high GGT level with MetS.
As GGT is responsible for maintaining glutathione homeostasis,
a high GGT level could be an indicator of high oxidative stress
levels35. These ﬁndings show that the association between GGT
and MetS might be explained by oxidative stress and low-grade,
chronic inﬂammation.
Several limitations should be considered when interpreting
the present ﬁndings. First, this study applied a cross-sectional
design, making it hard to set up a causal relationship between
GGT and MetS in children and adolescents. Although a consid-
erable relationship between GGT and MetS was noted in the
current study, it remains unclear whether GGT is a risk factor
directly included in the development of MetS or simply an
epiphenomenon. Future prospective research is warranted to
substantiate the causal relationship between GGT and MetS in
children and adolescents. Second, serum GGT levels are ele-
vated in some autoimmune disorders36,37; however, we could
not consider this aspect because the secondary data from the
KNHANES used in the present study did not include data per-
taining to the presence of autoimmune disorders. Finally, we
did not consider the physiological effect of puberty on insulin
resistance. Studies have shown that children and adolescents
experience transient insulin resistance during puberty38. Unfor-
tunately, because data on the pubertal stage were not included
in the KNHANES dataset, the pubertal stage of the participants
was not directly considered in our analysis. However, to mini-
mize the inﬂuence of this limitation, we analyzed data by sex
and involved age as a confounding variable in the multiple
logistic regression analysis. Further research is required to eluci-
date the relationship between the serum GGT level and MetS
according to pubertal stage, with a comparison between boys
and girls. Despite these potential limitations, the results of the
present study have good general applicability owing to the use
of a nationally representative sample of children and adoles-
cents in Korea. Additionally, the large sample of healthy partici-
pants of both sexes strengthens the reliability of the ﬁndings.
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The area under the receiver operating characteristic curve was 0.823
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In conclusion, serum GGT was positively associated with
MetS and its components in Korean children and adolescents.
The present ﬁndings make a contribution to our insight of the
relationship between serum GGT and MetS and its components
in children and adolescents. This study suggests that serum
GGT, which is a marker of inﬂammation and oxidative stress,
could be a helpful measure for identifying children and adoles-
cents with MetS.
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Additional Supporting Information may be found in the online version of this article:
Table S1 | Proportion of Upper GGT stratum (GGT ≥19 IU/L).
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